Characterization of the phospholemman knockout mouse heart: depressed left ventricular function with increased Na-K-ATPase activity.

PubWeight™: 1.77‹?› | Rank: Top 3%

🔗 View Article (PMID 18065526)

Published in Am J Physiol Heart Circ Physiol on December 07, 2007

Authors

James R Bell1, Erika Kennington, William Fuller, Kushal Dighe, Pamela Donoghue, James E Clark, Li-Guo Jia, Amy L Tucker, J Randall Moorman, Michael S Marber, Philip Eaton, Michael J Dunn, Michael J Shattock

Author Affiliations

1: Cardiovascular Division, King's College London, Rayne Institute, St Thomas' Hospital, London , UK.

Articles citing this

Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase. Am J Physiol Heart Circ Physiol (2008) 1.22

Massive palmitoylation-dependent endocytosis during reoxygenation of anoxic cardiac muscle. Elife (2013) 1.10

Phospholemman modulates the gating of cardiac L-type calcium channels. Biophys J (2010) 1.08

Regulation of in vivo cardiac contractility by phospholemman: role of Na+/Ca2+ exchange. Am J Physiol Heart Circ Physiol (2010) 1.06

Phospholemman and beta-adrenergic stimulation in the heart. Am J Physiol Heart Circ Physiol (2009) 1.05

Phosphomimetic mutations enhance oligomerization of phospholemman and modulate its interaction with the Na/K-ATPase. J Biol Chem (2011) 0.96

Regulation of the cardiac sodium pump. Cell Mol Life Sci (2012) 0.92

Phospholemman: a novel cardiac stress protein. Clin Transl Sci (2010) 0.89

Identification of caveolar resident proteins in ventricular myocytes using a quantitative proteomic approach: dynamic changes in caveolar composition following adrenoceptor activation. Mol Cell Proteomics (2015) 0.86

Dysfunction of ouabain-induced cardiac contractility in mice with heart-specific ablation of Na,K-ATPase beta1-subunit. J Mol Cell Cardiol (2009) 0.85

Regulation of cardiac contractility: high time for FXYD. Am J Physiol Heart Circ Physiol (2008) 0.84

Nitric oxide regulates cardiac intracellular Na⁺ and Ca²⁺ by modulating Na/K ATPase via PKCε and phospholemman-dependent mechanism. J Mol Cell Cardiol (2013) 0.83

Effects of PKA phosphorylation on the conformation of the Na,K-ATPase regulatory protein FXYD1. Biochim Biophys Acta (2009) 0.83

Human-induced pluripotent stem cell-derived cardiomyocytes for studies of cardiac ion transporters. Am J Physiol Cell Physiol (2013) 0.83

Maternal dietary supplementation with saturated, but not monounsaturated or polyunsaturated fatty acids, leads to tissue-specific inhibition of offspring Na+,K+-ATPase. J Physiol (2008) 0.81

Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2014) 0.79

Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality. Clin Transl Sci (2012) 0.76

Phospholemman, a major regulator of skeletal muscle Na(+)/K(+)-ATPase, is not mutated in probands with hypokalemic periodic paralysis. Exp Ther Med (2017) 0.75

The Structure and Function of the Na,K-ATPase Isoforms in Health and Disease. Front Physiol (2017) 0.75

Articles by these authors

The minimum information about a proteomics experiment (MIAPE). Nat Biotechnol (2007) 10.24

Current two-dimensional electrophoresis technology for proteomics. Proteomics (2004) 4.87

Human Proteinpedia enables sharing of human protein data. Nat Biotechnol (2008) 4.21

Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61

Cysteine redox sensor in PKGIa enables oxidant-induced activation. Science (2007) 3.29

Sample entropy analysis of neonatal heart rate variability. Am J Physiol Regul Integr Comp Physiol (2002) 3.29

Redox signaling in cardiac physiology and pathology. Circ Res (2012) 2.98

Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res (2002) 2.73

Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics (2005) 2.60

Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo. Arterioscler Thromb Vasc Biol (2011) 2.44

Heart rate characteristics and laboratory tests in neonatal sepsis. Pediatrics (2005) 2.31

Late intervention after anterior myocardial infarction: effects on left ventricular size, function, quality of life, and exercise tolerance: results of the Open Artery Trial (TOAT Study). J Am Coll Cardiol (2002) 2.19

Serine 68 phosphorylation of phospholemman: acute isoform-specific activation of cardiac Na/K ATPase. Cardiovasc Res (2005) 2.16

Anemia, apnea of prematurity, and blood transfusions. J Pediatr (2012) 2.08

Experimental hyperleptinemia in neonatal rats leads to selective leptin responsiveness, hypertension, and altered myocardial function. Hypertension (2013) 2.06

Phospholemman-phosphorylation mediates the beta-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res (2005) 1.94

Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure. Circ Res (2005) 1.92

Activation of p38 mitogen-activated protein kinase contributes to the early cardiodepressant action of tumor necrosis factor. J Am Coll Cardiol (2006) 1.89

Phospholemman phosphorylation mediates the protein kinase C-dependent effects on Na+/K+ pump function in cardiac myocytes. Circ Res (2006) 1.89

Remote intermittent ischemia before coronary artery bypass graft surgery: a strategy to reduce injury and inflammation? Basic Res Cardiol (2011) 1.81

Protein sulfenation as a redox sensor: proteomics studies using a novel biotinylated dimedone analogue. Mol Cell Proteomics (2007) 1.81

Abnormal heart rate characteristics preceding neonatal sepsis and sepsis-like illness. Pediatr Res (2003) 1.73

Hyperubiquitination of proteins in dilated cardiomyopathy. Proteomics (2003) 1.70

Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J Biol Chem (2008) 1.64

Calcineurin regulates NFAT-dependent iNOS expression and protection of cardiomyocytes: co-operation with Src tyrosine kinase. Cardiovasc Res (2006) 1.64

Widespread sulfenic acid formation in tissues in response to hydrogen peroxide. Proc Natl Acad Sci U S A (2004) 1.63

The regulated assembly of a PKCepsilon complex controls the completion of cytokinesis. Nat Cell Biol (2008) 1.61

Complex signals bioinformatics: evaluation of heart rate characteristics monitoring as a novel risk marker for neonatal sepsis. J Clin Monit Comput (2013) 1.58

Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury. Proc Natl Acad Sci U S A (2011) 1.58

Oxidant-induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem (2006) 1.58

Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation. Cardiovasc Res (2006) 1.56

Heart rate characteristics and clinical signs in neonatal sepsis. Pediatr Res (2007) 1.56

Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol (2015) 1.52

Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling. Circulation (2012) 1.51

Ischemia-induced phosphorylation of phospholemman directly activates rat cardiac Na/K-ATPase. FASEB J (2003) 1.45

Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res (2008) 1.44

Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr Opin Pharmacol (2008) 1.41

Phospholemman inhibition of the cardiac Na+/Ca2+ exchanger. Role of phosphorylation. J Biol Chem (2006) 1.39

2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease. Proteomics (2009) 1.39

Detection and mapping of widespread intermolecular protein disulfide formation during cardiac oxidative stress using proteomics with diagonal electrophoresis. J Biol Chem (2004) 1.37

Sample entropy. Methods Enzymol (2004) 1.35

Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice. Am J Physiol Heart Circ Physiol (2004) 1.34

Ischemic preconditioning exaggerates cardiac damage in PKC-delta null mice. Am J Physiol Heart Circ Physiol (2004) 1.34

Thymosin beta4 facilitates epicardial neovascularization of the injured adult heart. Ann N Y Acad Sci (2010) 1.33

The utility of N,N-biotinyl glutathione disulfide in the study of protein S-glutathiolation. Mol Cell Proteomics (2005) 1.32

Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia. Circ Res (2003) 1.31

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics (2006) 1.31

Sample asymmetry analysis of heart rate characteristics with application to neonatal sepsis and systemic inflammatory response syndrome. Pediatr Res (2003) 1.30

Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol (2005) 1.30

Abnormal heart rate characteristics are associated with neonatal mortality. Pediatr Res (2004) 1.29

Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule. Br J Pharmacol (2004) 1.28

Differential distribution and regulation of mouse cardiac Na+/K+-ATPase alpha1 and alpha2 subunits in T-tubule and surface sarcolemmal membranes. Cardiovasc Res (2006) 1.28

Bioactivity and pharmacological actions of carbon monoxide-releasing molecules. Curr Pharm Des (2003) 1.27

Phospholemman-mediated activation of Na/K-ATPase limits [Na]i and inotropic state during beta-adrenergic stimulation in mouse ventricular myocytes. Circulation (2008) 1.27

A new algorithm for detecting central apnea in neonates. Physiol Meas (2011) 1.26

Mouse isolated perfused heart: characteristics and cautions. Clin Exp Pharmacol Physiol (2003) 1.26

Detection, quantitation, purification, and identification of cardiac proteins S-thiolated during ischemia and reperfusion. J Biol Chem (2002) 1.25

Increased nonstationarity of neonatal heart rate before the clinical diagnosis of sepsis. Ann Biomed Eng (2004) 1.24

Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol (2007) 1.24

Identification of an endogenous inhibitor of the cardiac Na+/Ca2+ exchanger, phospholemman. J Biol Chem (2005) 1.23

Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat Med (2012) 1.23

Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase. Am J Physiol Heart Circ Physiol (2008) 1.22

FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C. Am J Physiol Cell Physiol (2009) 1.20

Endotoxin depresses heart rate variability in mice: cytokine and steroid effects. Am J Physiol Regul Integr Comp Physiol (2009) 1.19

Metal carbonyls: a new class of pharmaceuticals? Angew Chem Int Ed Engl (2003) 1.19

Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. JACC Cardiovasc Imaging (2012) 1.18

Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis. Mol Cell Proteomics (2009) 1.18

Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem (2002) 1.17

Pathogen-induced heart rate changes associated with cholinergic nervous system activation. Am J Physiol Regul Integr Comp Physiol (2010) 1.17

Androgens target prohibitin to regulate proliferation of prostate cancer cells. Oncogene (2004) 1.16

Altered contractility and [Ca2+]i homeostasis in phospholemman-deficient murine myocytes: role of Na+/Ca2+ exchange. Am J Physiol Heart Circ Physiol (2006) 1.16

Redox modification of cell signaling in the cardiovascular system. J Mol Cell Cardiol (2011) 1.15

Effects of phospholemman downregulation on contractility and [Ca(2+)]i transients in adult rat cardiac myocytes. Am J Physiol Heart Circ Physiol (2003) 1.15

Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent. Nat Med (2011) 1.13

Impact of the CHA2DS2-VASc score on anticoagulation recommendations for atrial fibrillation. Am J Med (2012) 1.13

Future treatment strategies in ST-segment elevation myocardial infarction. Lancet (2013) 1.12

The role of bioinformatics in two-dimensional gel electrophoresis. Proteomics (2003) 1.12

Targeting p38-MAPK in the ischaemic heart: kill or cure? Curr Opin Pharmacol (2008) 1.11

The neuroproteomics of schizophrenia. Biol Psychiatry (2011) 1.11

Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes. J Appl Physiol (1985) (2005) 1.11

Cardiac ischemia causes inhibition of the Na/K ATPase by a labile cytosolic compound whose production is linked to oxidant stress. Cardiovasc Res (2003) 1.11